COMP <GO>
IRWD vs MRK // DIVIDEND YIELD & FCF PAYOUT SAFETY
Ironwood Pharmaceuticals Inc. (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: IRWD 3
— MRK 8
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: MRK
LAST: $3.50 (-3.31%) • MKT CAP: $598.2M
dividend-safety
0.00%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
dividend-safety
2.26%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRWD VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRWD | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 20.70% | +64.30 | IRWD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.9x | 15.3x | -11.40 | IRWD | /valuation <GO> |
| Free Cash Flow Yield | 21.23% | 3.42% | +17.81 | IRWD | /fcf-yield <GO> |
| Operating Margin | 33.30% | 34.30% | -1.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | 8.10% | 28.10% | -20.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -15.70% | 1.30% | -17.00 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.2 | 51.7 | -5.50 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.2x | 18.4x | +4.80 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $598.2M | $361.02B | -$360.42B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRWD REV | MRK REV | IRWD GROSS % | MRK GROSS % | IRWD FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $296.2M | $65.01B | — | 74.8% | $127.0M | $12.36B |
| FY 2024 | $351.4M | $64.17B | — | 76.3% | $103.4M | $18.10B |
| FY 2023 | $442.7M | $60.12B | — | — | $183.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRWD // BETA —
MRK // BETA 0.92